Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704389 | SCV000529228 | likely benign | not provided | 2019-09-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000473158 | SCV000556673 | likely benign | Tuberous sclerosis 2 | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000562794 | SCV000675715 | likely benign | Hereditary cancer-predisposing syndrome | 2016-05-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000473158 | SCV002041223 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004000468 | SCV004816962 | likely benign | Tuberous sclerosis syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing |